CompletedNot Applicable

Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health

United States11 participantsStarted 2025-03-19

Plain-language summary

This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years or older * Self reported gastrointestinal symptoms consistent with disorders of gut-brain interaction * English speaking * Willingness to participate in all hypnotherapy sessions \& complete all pre- and post-session surveys Exclusion Criteria: * Under 18 years * Pregnant women * Prisoners * Children * Individuals with active or a history of severe mental illness (e.g. active psychosis, dissociative disorders) * A hypnotic susceptibility score in the low range (SHSS; total = 0-3)

What they're measuring

Patient- Reported Outcome Measurement Information System (PROMIS)

Timeframe: 4 months

General Anxiety Disorder-7 (GAD-7)

Timeframe: 4 months

Patient Health Questionnaire-9 (PHQ-9)

Timeframe: 4 months

Patient Reported Outcome (PRO)

Timeframe: 4 months

Trial details

NCT IDNCT06890663

SponsorUniversity of Central Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-30

View on ClinicalTrials.gov More Gastrointestinal Disease trials